WHAT WE'RE UP AGAINST
Breast cancer has now become the most commonly diagnosed cancer worldwide, with around 2.3 million people diagnosed with the disease globally each year.
THE MISSION
Breast Cancer Trials is dedicated to improving and saving the lives of every person affected by breast cancer.
As the largest independent oncology clinical trials research group in Australia and New Zealand, we are on the front line of breast cancer treatment and care. We see the impact breast cancer has on people every day and want to end the pain and loss it causes.
We are on a mission to see a world where no more lives are cut short by breast cancer and you can help by hosting a Pink Bloom Party!
YOUR SUPPORT WILL HELP FUND
WHY SUPPORT US
Since 1978, Breast Cancer Trials has been at the forefront of breast cancer research, bringing together Australia’s top experts to find smarter, kinder, and more effective treatments.
Breast cancer trials research is the only way to get new and improved treatments to all Australians living with breast cancer.
Our work over the last 46 years has seen treatments like Herceptin, Exemestane, Letrozole and Tamoxifen become widely available, saving millions of lives.
Sadly, 9 people still die every day from breast cancer and we will not stop until no more lives are cut short by this terrible disease. Your Pink Bloom Party will help save lives, today, tomorrow and forever.
OUR RESEARCH
Breast cancer clinical trials research is a team effort – researchers, clinical trial participants and supporters working together to help ensure no more lives are cut short by breast cancer. Below are a few of our current clinical trials. To find out more about our life-saving research and the impact you can make register to host a Pink Bloom Party now. We look forward to seeing how you bloom this October!
OPTIMA Clinical Trial
Research Lead: Dr Belinda Kiely
The OPTIMA clinical trial is investigating if a simple test on tumour tissue can tell us if a patient may be spared chemotherapy and its short and long-term side effects without compromising their chance of survival.
EXPERT Clinical Trial
Research Lead: Dr Boon Chua
The EXPERT clinical trial is investigating whether a genomic test can identify women with good prognosis, early-stage breast cancer who can safely avoid radiation therapy and its side effects
NEO-N Clinical Trial
Research Lead: Dr Sherene Loi
The Neo-N clinical trial (Cohort-C) builds on earlier results which showed the benefit of using immunotherapy, which helps boost the body’s own immune system to fight the cancer, in combination with chemotherapy to treat early-stage triple negative breast cancer.
CAMBRIA-2 Clinical Trial
Research Lead: Dr Nicholas Zdenkowski
The CAMBRIA-2 clinical trial aims to find out if giving a new treatment known as a ‘selective estrogen receptor degrader’ is better at stopping breast cancer from coming back compared with the standard hormone treatments.
OLIO Clinical Trial
Research Lead: Dr Stephen Luen
The OLIO clinical trial aims to provide new treatment options for young women with hormone receptor (HR) positive, HER2 negative breast cancer.
